Of note, post-fourth-dose neutralizing antibody titers and CD8+ T-cell responses in PLWH who experienced a breakthrough infection were significantly higher than among SARS-CoV-2-naive PLWH at this same time (p = 0.001 and p = 0.03, respectively; Figure 3A and Figure 3C). The gene discussed is CD8A; the disease is infection.